Feng Jifeng is a Chinese oncologist at Jiangsu Cancer Hospital and Nanjing Medical University, both located in Nanjing, China.[1] He specializes in the diagnosis and treatment of malignant tumors such as lung cancer, breast cancer, and lymphoma. He has a special interest in aspects of biotherapy and the correlation between dosage of chemotherapeutics and their curative effect and toxicity. He currently holds the following positions:
- Director of national pharmaceutical clinical trial institute in Jiangsu Cancer Hospital
- Chief physician of Jiangsu Cancer Hospital
- Director of Quality Control Centre of Jiangsu Medical Oncology and Chinese Medical Association
- Vice director of Chinese Society of Clinical Cancer Chemotherapy of Chinese Anti-Cancer Association
- Editor-in-chief of the Journal of International Translational Medicine
Feng Jifeng | |
|---|---|
| Nationality (legal) | Chinese |
| Scientific career | |
| Institutions | Jiangsu Cancer Hospital Nanjing Medical University |
References edit
- ^ "Brief introduction for editors: Prof. Feng Jifeng". Journal of International Translational Medicine. Archived from the original on 15 July 2014. Retrieved 9 July 2014.